Disc lays off 20% of employees to steady ship after FDA rejection of rare disease drug
Disc lays off 20% of employees to steady ship after FDA rejection of rare disease drug
Body unavailable. Use the original source.
Disc lays off 20% of employees to steady ship after FDA rejection of rare disease drug
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.